15th INTERNATIONAL CONGRESS OF PARKINSON'S

Abstracts
by topic
86
Abstracts by Topic
27 Mitochondrial D-loop variations in Indian patients with Friedreich’s
ataxia (FRDA) mutation – Identification of novel markers
I. Singh, F. Mohammed, A. Srivastava, S. Singh, M. Mukerji (New
Delhi, Delhi, India)
28 Genome wide analysis of spinocerebellar ataxia 12 (SCA12) subphenotypes
revealed chr1q21.3 region as a potential candidate
genetic modifier
A.K. Srivastava, F. Mohammed, P. Jha, S. Singh, M. Mukerji, M. Behari
(New Delhi, Delhi, India)
29 Cerebellar ataxia caused by hereditary folate malabsorption
T. Stojkovic, M. Svetel, V. Dobricic, I. Novakovic, V. Kostic (Belgrade,
Serbia)
30 The prevalence of antigliadin antibodies in patients with cerebellar
diseases compared with normal control
C.-S. Su, C.-W. Liou, K.-T. Liu, M.-Y. Lan, Y.-Y. Chang (Kaohsiung,
Taiwan)
31 Assessing degenerative cerebellar features by transcranial
sonography: Evidence from Friedreich’s ataxia
M. Synofzik, J. Godau, K. Srulijes, T. Lindig, L. Schöls, D. Berg
(Tübingen, Germany)
32 Otoneurological findings in spinocerebellar ataxia
B.S. Zeigeilboim, R.S. Santos, H. Mengelberg, A.L. Jurkiewicz,
H.G. Teive, E.M. Abdulmasshi (Curitiba, Pr, Brazil)
33 Electronystagmography findings in spinocerebelar ataxia type 3
(SCA3) and type 2 (SCA2)
R.S. Santos, B.S. Zeigelboim, A.L. Jurkiewicz, H.G. Teive,
E.M. Abdulmasshi, W.O. Arruda (Curitiba, Pr, Brazil)
Basic Science
34 Patients who had prior peripheral surgery for cervical dystonia
experience improvement from subsequent pallidal DBS that is
comparable to de novo patients. These patients should not be
excluded from subsequent DBS surgery
M. Alam, H.-H. Capelle, K. Schwabe, J.K. Krauss (Hannover, Germany)
35 Expression of synaptophysin and synaptotagmin-XI proteins in
human substantia nigra pars compacta during normal aging
P.A. Alladi, A. Mahadevan, S.K. Shankar, T.R. Raju (Bangalore,
Karnataka, India)
36 Glucerebrosidase deficiency and dopaminergic cell death: Relevance
to Parkinson’s disease
D. Alvarez-Fischer, C. Noelker, L. Lu, A. Sturn, R. Roscher, E.C. Hirsch,
A. Hartmann (Marburg, Germany)
37 Identification of a critical region within LRRK2 that mediates the
interaction with the cell death adaptor protein FADD
N. Antoniou, P. Valkimadi, H. Rideout (Athens, Greece)
38 A neurocomputational model linking reward predicting function of
dopamine, assignment of salience and repetitive behaviours
C.P. Arun (London, United Kingdom)
39 Rise in endogenous morphine in parkinsonism is not corrected by
levodopa
G. Charron, E. Doudnikoff, A. Laux, A. Berthet, G. Porras, M.-
H. Canron, A. Vital, Y. Goumon, E. Bezard (Bordeaux, France)
40 Dramatic alteration of proteasome activity of striatal neurons in
L-dopa-induced dyskinesia
A. Berthet, P. Barroso-Chinea, G. Porras, S. Fasano, Q. Li, B. Bloch, M.-
L. Martin-Negrier, E. Bezard (Bordeaux, France)
41 Parkinson’s – Is time on your side?
M. Bienkiewicz, C. Craig (Belfast, United Kingdom)
42 Objectively identifying upper limb freezing (ULF) in individuals
with Parkinson’s disease (PD) during bimanual coordination
M.J.N. Brown, Q.J. Almeida, F. Rahimi (Waterloo, Ontario, Canada)
43 Evaluating the effects of dopaminergic treatment on upper limb
freezing (ULF) in individuals with Parkinson’s disease (PD)
M.J.N. Brown, Q.J. Almeida, F. Rahimi (Waterloo, Ontario, Canada)
44 Differential pathomechanisms of disease-associated variants of the
mitochondrial chaperone mortalin in Parkinson’s disease
L.F. Burbulla, H. Kato, D. Rapaport, H. Wolburg, D. Woitalla,
O. Riess, R. Krüger (Tübingen, Germany)
45 Multidisciplinary rehabilitation team for Parkinson’s: An easily
reproducible model for treatment in underserved populations
J.M. Dean (Longmont, Colorado, USA)
46 Distinct roles in vivo for the ubiquitin-proteasome system and the
autophagy-lysosomal pathway in the degradation of a-synuclein
D. Ebrahimi-Fakhari, V.K. Unni, E. Rockenstein, E. Masliah,
B.T. Hyman, P.J. McLean (Charlestown, Massachusetts, USA)
47 Step width during obstacle crossing in patients with Parkinson’s
disease is a predictor of the UPDRS gait and posture clinical score:
An ‘on’ and ‘off’ study
F.P. Faria, R. Vitorio, L.B. Gobbi, C.A. Silveira, M.J.D. Caetano,
Q. Almeida, F. Stella (Waterloo, Canada)
48 Motor and locomotor behavioral changes induced by repetitive
electromagnetic stimulation of the spinal cord
P.M. Gondim Sales, L.M.S. Andrade, F.H. Rola, F.A.A. Gondim
(Fortaleza, Ceará, Brazil)
49 Parkin mediates proteosome-independent recovery of hypothalamic
tuberoinfundibular dopamine neurons following acute injury
M. Benskey, B. Behrouz, K.J. Lookingland, S.-H. Baek, J.L. Goudreau
(East Lansing, Michigan, USA)
50 Role of TPPP/p25 on alpha-synuclein-mediated oligodendroglial
degeneration and the protective effect of SIRT2 inhibition in a
cellular model of multiple system atrophy
T. Hasegawa, T. Baba, M. Kobayashi, M. Konno, N. Sugeno,
A. Kikuchi, A. Takeda (Sendai, Miyagi, Japan)
51 Curcumin relieves copper/iron inhibition of NEIL-initiated repair
of oxidized base damage in neuroblastoma cells: Therapeutic
implications for neurodegenerative diseases
M.L. Hegde, P.M. Hegde, L.M. Holthauzen, T.K. Hazra, J.K.S. Rao,
S. Mitra (Galveston, Texas, USA)
52 50U incobotulinumtoxinA demonstrates lower potency than 50U
onabotulinumtoxinA with concurrent lower light-chain activity and
atypical substrate cleavage
T. Hunt, K. Clarke, D. Rupp, G. Shimizu, J. Weidler (Irvine, California,
USA)
53 Characterization of ion-permeable alpha-synculein pores in lipid
membranes – A possible mechanism of neuronal cell death in the
pathogenesis of synucleinopathies?
F. Schmidt, J. Levin, H. Thomas, K. Frits, G. Armin, B. Kai (München,
Germany)